Lyell Immunopharma, Inc. (LYEL) Net Income by Year
Lyell Immunopharma, Inc. reported a net loss of $274.4M in fiscal year 2025. This represents an increase of 20.0% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $248.5M net loss. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Lyell Immunopharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LYEL Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
LYEL Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Lyell Immunopharma, Inc. financials
Frequently Asked Questions
What was Lyell Immunopharma, Inc.'s net income in fiscal year 2025?
Lyell Immunopharma, Inc. reported a net loss of $274.4M in fiscal year 2025.
How fast is Lyell Immunopharma, Inc.'s net income growing?
Lyell Immunopharma, Inc. (LYEL) net income rose by 20.0% year over year, from -$343.0M to -$274.4M in fiscal year 2025.
What is Lyell Immunopharma, Inc.'s net income over the last twelve months?
Lyell Immunopharma, Inc. (LYEL) reported a $248.5M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Lyell Immunopharma, Inc.'s net income changed over the years?
Across the 7 fiscal years this page covers, Lyell Immunopharma, Inc. (LYEL) net income went from -$129.4M in fiscal year 2019 to -$274.4M in fiscal year 2025.
What was Lyell Immunopharma, Inc.'s net income in the most recent quarter?
Lyell Immunopharma, Inc. (LYEL) reported -$44.8M in net income in Q2 2026. This represents a decrease of 4.9% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Lyell Immunopharma, Inc. (LYEL) reported on that line in every period on record.